Subtype
Malignant Bile Duct Neoplasm
CI-CAN-00003138Explore in graph →
223 active trials3 approved drugs29 evidence items
- NCIt
- C227650
Loading cancer entity…
Loading cancer entity…
Subtype
CI-CAN-00003138Explore in graph →
Clinical trials
883 studies whose conditions map to this entity or one of its descendants. Status and phase are as posted on ClinicalTrials.gov. 50 studies per page.
Computedformula ci-trial-intel-v1 · interventional studies · entity + NCIt descendants · hover a figure for its formulaCompare cancersTerminated studies (119)
| NCT | Title | Status | Phase | Enrollment (n) | Sponsor | Countries | Last update | Source |
|---|---|---|---|---|---|---|---|---|
| NCT01313377 | Gemcitabine Hydrochloride and Oxaliplatin or Observation in Treating Patients With Biliary Tract Cancer That Has Been Removed by Surgery | completed | Phase 3 | 190 | UNICANCEROTHER | 1 | Jan 25, 2017 | clinicaltrials |
| NCT00465023 | Proton Beam Irradiation for the Treatment of Unresectable Hepatocellular Cancer or Hepatic Metastases | completed | N/A | 16 | Massachusetts General HospitalOTHER | 0 | Jan 20, 2017 | clinicaltrials |
| NCT02893085 | Pancreatico-biliary Tumor Mutation Profiling in Bile Samples(ONCOBIL) | completed | — | 100 | CHU de ReimsOTHER | 1 | Dec 28, 2016 | clinicaltrials |
| NCT00009893 | Combination Chemotherapy in Treating Patients With Unresectable or Metastatic Biliary Tract or Gallbladder Cancer | completed | Phase 2 | 42 | Alliance for Clinical Trials in OncologyOTHER | 1 | Dec 7, 2016 | clinicaltrials |
| NCT00059865 | Gemcitabine Plus Pemetrexed Disodium in Treating Patients With Unresectable or Metastatic Biliary Tract or Gallbladder Cancer | completed | Phase 1 / Phase 2 | 68 | Alliance for Clinical Trials in OncologyOTHER | 1 | Dec 7, 2016 | clinicaltrials |
| NCT01642875 | Early Oral Versus Enteral Nutrition After Pancreatoduodenectomy | unknown | Phase 4 | 96 | Medical University of WarsawOTHER | 1 | Nov 23, 2016 | clinicaltrials |
| NCT02954302 | Proximal Roux-en-y Gastrojejunal Anastomosis on Delayed Gastric Emptying After Pylorus-resecting Pancreaticoduodenectomy | unknown | N/A | 140 | The First Affiliated Hospital of Xiamen UniversityOTHER | 1 | Nov 3, 2016 | clinicaltrials |
| NCT01111591 | Cyclooxygenase-2 Inhibitor for Adjuvant Anticancer Effect in Patients With Biliary-pancreas Cancer | unknown | Phase 4 | 220 | Seoul National University HospitalOTHER | 1 | Oct 28, 2016 | clinicaltrials |
| NCT02607826 | Short-term Starvation vs. Normal Diet Before Chemotherapy of Solid Tumors | unknown | N/A | 298 | University Hospital TuebingenOTHER | 0 | Oct 28, 2016 | clinicaltrials |
| NCT01041612 | Comparing Covered Self-expandable Metallic Stent (SEMS) Above/Across the Sphincter of Oddi | completed | Phase 4 | 120 | Taewoong Medical Co., Ltd.INDUSTRY | 2 | Oct 21, 2016 | clinicaltrials |
| NCT00753675 | Vandetanib Gemcitabine Or Placebo Plus Gemcitabine Or Vandetanib Monotherapy In Advanced Biliary Tract Cancer(VANGOGH) | completed | Phase 2 | 174 | Genzyme, a Sanofi CompanyINDUSTRY | 1 | Oct 10, 2016 | clinicaltrials |
| NCT02665494 | Biliary Cancer in Italy: a Study on Cholangiocarcinoma cAUSEs and Risk Factors | unknown | — | 500 | Fondazione del Piemonte per l'OncologiaOTHER | 1 | Sep 23, 2016 | clinicaltrials |
| NCT01151761 | Phase II SBRT & Chemo for Unresectable Cholangiocarcinoma Followed by Liver Transplantation | terminated | Phase 2 | 2 | Stanford UniversityOTHER | 1 | Jul 29, 2016 | clinicaltrials |
| NCT02436564 | In Vitro Models of Liver and Pancreatic Cancer | unknown | — | 75 | Cambridge University Hospitals NHS Foundation TrustOTHER | 1 | Jul 14, 2016 | clinicaltrials |
| NCT00767234 | Permission to Collect Blood Over Time for Research | terminated | — | 104 | Stanford UniversityOTHER | 1 | Jul 11, 2016 | clinicaltrials |
| NCT01425879 | MK2206 in Treating Patients With Advanced Refractory Biliary Cancer That Cannot Be Removed by Surgery | completed | Phase 2 | 8 | National Cancer Institute (NCI)NIH | 1 | Jun 17, 2016 | clinicaltrials |
| NCT00304135 | Fluorouracil, Cisplatin, and Radiation Therapy or Gemcitabine and Oxaliplatin in Treating Patients With Nonmetastatic Biliary Tract Cancer That Cannot Be Removed By Surgery | completed | Phase 2 / Phase 3 | 34 | Federation Francophone de Cancerologie DigestiveOTHER | 1 | May 30, 2016 | clinicaltrials |
| NCT01242605 | ABC-04 a Study of Cisplatin, Gemcitabine and Selumetinib in Patients With Advanced Biliary Tract Cancer(ABC-04) | completed | Phase 1 | 13 | University College, LondonOTHER | 1 | May 13, 2016 | clinicaltrials |
| NCT02468076 | Radiofrequency Ablation for Biliopancreatic Malignancy(IGNITE-1) | completed | Phase 2 | 18 | Universitaire Ziekenhuizen KU LeuvenOTHER | 1 | May 11, 2016 | clinicaltrials |
| NCT01267344 | A Randomized Study of GEMOX With or Without Cetuximab in Locally Advanced and Metastatic BTC(BTC) | completed | Phase 2 | 122 | National Health Research Institutes, TaiwanOTHER | 1 | May 4, 2016 | clinicaltrials |
| NCT01875549 | Comparison Between Unilateral Versus Bilateral Stenting for Malignant Hilar Biliary Obstruction to Use a LCD Stent | withdrawn | N/A | 0 | Kwang Hyuck LeeOTHER | 0 | Apr 26, 2016 | clinicaltrials |
| NCT00553332 | Selumetinib in Treating Patients With Biliary Cancer That Cannot Be Removed By Surgery | completed | Phase 2 | 29 | National Cancer Institute (NCI)NIH | 1 | Apr 22, 2016 | clinicaltrials |
| NCT00975039 | Study Using WST11 in Patients With Non-Resectable or Inoperable Cholangiocarcinoma | terminated | Phase 2 | 8 | Steba Biotech S.A.OTHER | 1 | Apr 18, 2016 | clinicaltrials |
| NCT02479178 | A Study of BIND-014 in Patients With Urothelial Carcinoma, Cholangiocarcinoma, Cervical Cancer and Squamous Cell Carcinoma of the Head and Neck(iNSITE2) | terminated | Phase 2 | 73 | BIND TherapeuticsINDUSTRY | 2 | Apr 14, 2016 | clinicaltrials |
| NCT02683538 | Radiofrequency Ablation Using Octopus Electrodes for Treatment of Focal Liver Malignancies | completed | Phase 2 | 196 | Seoul National University HospitalOTHER | 1 | Apr 5, 2016 | clinicaltrials |
| NCT02526771 | Conventional or Unconventional Lymph Node Dissection During Resection of Intrahepatic Cholangiocarcinoma | unknown | N/A | 100 | Eastern Hepatobiliary Surgery HospitalOTHER | 1 | Apr 1, 2016 | clinicaltrials |
| NCT01914289 | Prognosis of Resection and Radiotherapy in the Treatment of Intrahepatic Cholangiocarcinoma Patients | unknown | N/A | 200 | Eastern Hepatobiliary Surgery HospitalOTHER | 1 | Mar 31, 2016 | clinicaltrials |
| NCT02588755 | TACE Plus Tegafur Versus TACE for Intrahepatic Cholangiocarcinoma After Curative Resection | unknown | N/A | 180 | Eastern Hepatobiliary Surgery HospitalOTHER | 1 | Mar 31, 2016 | clinicaltrials |
| NCT01692704 | Downsizing of Unresectable Cholangiocarcinoma by Combined Intravenous and Intra-arterial Chemotherapy | completed | Phase 1 / Phase 2 | 12 | University of ZurichOTHER | 1 | Mar 25, 2016 | clinicaltrials |
| NCT00414843 | Storage of Bile From Routine Procedures to Study Risk Factors | terminated | — | 390 | Indiana UniversityOTHER | 1 | Feb 23, 2016 | clinicaltrials |
| NCT00919061 | Gemcitabine and Cisplatin Plus Sorafenib in Patients With Advanced Biliary Tract Carcinomas Naive to Systemic Therapy | completed | Phase 2 | 39 | Memorial Sloan Kettering Cancer CenterOTHER | 1 | Feb 3, 2016 | clinicaltrials |
| NCT00003411 | Radiation Therapy in Treating Patients With Bile Duct, Gallbladder, or Pancreatic Cancer | completed | Phase 1 | — | University of PittsburghOTHER | 1 | Jan 18, 2016 | clinicaltrials |
| NCT02028845 | Loop-tipped Guidewire in Selective Biliary Cannulation | completed | N/A | 200 | Ajou University School of MedicineOTHER | 1 | Jan 5, 2016 | clinicaltrials |
| NCT02156700 | Quantitative Real-time Ultrasound Elastography for Characterisation of Liver Tumors | completed | — | 196 | University Hospital DubravaOTHER | 1 | Dec 24, 2015 | clinicaltrials |
| NCT02504957 | Photodynamic Therapy With Polyhematoporphyrin for Malignant Biliary Obstruction | completed | N/A | 88 | Medical University of ViennaOTHER | 0 | Oct 26, 2015 | clinicaltrials |
| NCT02582541 | Endoscopic Biliary RFA of Malignant Bile Duct Obstruction | unknown | N/A | 100 | The Second Hospital of Nanjing Medical UniversityOTHER | 1 | Oct 21, 2015 | clinicaltrials |
| NCT00397384 | Erlotinib Hydrochloride and Cetuximab in Treating Patients With Advanced Gastrointestinal Cancer, Head and Neck Cancer, Non-Small Cell Lung Cancer, or Colorectal Cancer | completed | Phase 1 | 43 | National Cancer Institute (NCI)NIH | 1 | Sep 30, 2015 | clinicaltrials |
| NCT01073839 | Adjuvant Cisplatin Plus Gemcitabine in Operable Cholangiocellular Carcinoma. | completed | Phase 1 / Phase 2 | 33 | University of ZurichOTHER | 1 | Sep 18, 2015 | clinicaltrials |
| NCT01501604 | BKM120 in Cancers With PIK3CA Activating Mutations | withdrawn | Phase 2 | 0 | Massachusetts General HospitalOTHER | 0 | Sep 17, 2015 | clinicaltrials |
| NCT02548195 | Oxaliplatin+Gemcitabine vs Capecitabine as Adjuvant Therapy for Intrahepatic Cholangiocarcinoma | unknown | Phase 3 | 286 | Shanghai Zhongshan HospitalOTHER | 1 | Sep 14, 2015 | clinicaltrials |
| NCT00630890 | Cyberknife Radiosurgery Boost for Hilar Cholangiocarcinoma (Klatskin Tumor) | terminated | Phase 1 | 11 | University of California, San FranciscoOTHER | 1 | Sep 11, 2015 | clinicaltrials |
| NCT02528526 | Effects of OXY111A in Primary and Secondary Hepato-Pancreato-Biliary Neoplasm(OXY1A) | unknown | Phase 1 / Phase 2 | 69 | University of ZurichOTHER | 1 | Aug 19, 2015 | clinicaltrials |
| NCT01093222 | Sorafenib Tosylate and Erlotinib Hydrochloride in Treating Patients With Locally Advanced, Unresectable, or Metastatic Gallbladder Cancer or Cholangiocarcinoma | completed | Phase 2 | 40 | National Cancer Institute (NCI)NIH | 1 | Jun 30, 2015 | clinicaltrials |
| NCT02027311 | Etomidate vs. Midazolam for Sedation During ERCP | completed | Phase 4 | 63 | Cheju Halla General HospitalOTHER | 1 | Jun 29, 2015 | clinicaltrials |
| NCT00624182 | Gemcitabine With Peptide Vaccine Therapy in Treating Patients With Bile Duct Cancer | suspended | Phase 1 | 9 | Akita University HospitalOTHER | 1 | Jun 23, 2015 | clinicaltrials |
| NCT01775280 | Response of Hepatic Tumors to Radioembolization(RESRAD) | withdrawn | Phase 2 | 0 | University of ZurichOTHER | 1 | Jun 9, 2015 | clinicaltrials |
| NCT00544193 | Gemcitabine and Radiation Therapy in Treating Patients With Locally Advanced Upper Gastrointestinal Cancer | completed | Phase 1 | 16 | City of Hope Medical CenterOTHER | 0 | Jun 8, 2015 | clinicaltrials |
| NCT00907413 | Photodynamic Therapy (PDT) Trial for Palliation of Cholangiocarcinoma(PDT) | terminated | Phase 3 | 50 | Weill Medical College of Cornell UniversityOTHER | 1 | Jun 3, 2015 | clinicaltrials |
| NCT01439685 | Comparison of Biliary Stenting Alone vs. Stenting With Photodynamic Therapy (PDT) During ERCP(PDT) | withdrawn | — | 0 | Weill Medical College of Cornell UniversityOTHER | 1 | Jun 3, 2015 | clinicaltrials |
| NCT01389414 | Panitumumab Plus Gemcitabine and Oxaliplatin (GEMOX)Versus GEMOX Alone to Treat Advanced Biliary Tract Adenocarcinoma(Vecti-BIL) | completed | Phase 2 | 89 | Prof. Massimo AgliettaOTHER | 1 | May 28, 2015 | clinicaltrials |
Data updated 23 days agoSource updated Jan 25, 2017source: clinicaltrials